Walgreens Swings to Loss as COVID Hits Sales

The pandemic had an adverse impact on sales in the third quarter of about $700 million to $750 million though sales rose in the U.S.

Walgreens Boots Alliance reported lower-than-expected quarterly earnings on Thursday as sales took a big hit from the coronavirus pandemic despite a 3% increase in U.S. same-store sales.

The retailer said the pandemic had an adverse impact on sales in the third quarter of about $700 million to $750 million, most of which was related to its international business, with the U.K. particularly hard hit by stay-at-home orders.

There was “a dramatic reduction in footfall in Boots UK stores — down 85 percent in April — as consumers were advised to leave home only for food and medicine,” Walgreens said, adding that while stores remained open during the U.K. lockdown, its largest our largest premium beauty and fragrance counters were effectively closed.

For the quarter, Walgreens’ total revenue rose only 0.1% to $34.63 billion. It posted a net loss of $1.7 billion, or $1.95 per share, compared to net income of $1 billion, or $1.13 per share, a year earlier.

The loss included 61 cents to 65 cents per share in COVID-19-related costs and impacts. Excluding those items, Walgreens earned 83 cents per share, missing analysts’ estimates of $1.17 per share.

CEO Stefano Pessina said the company would “accelerate our ongoing investments in digital transformation and neighborhood health destinations” in response to the crisis. It is also raising its annual cost-savings target to more than $2 billion by 2022.

Source: CFO (2020)

Share on facebook
Share on Facebook
Share on linkedin
Share on LinkedIn
Thank you! Your subscription has been confirmed. You'll hear from us soon.